| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AMSAmerican Shared Hospital Services | 14.07M | 2.15 | 6.52 | 32.9% | -7.65% | -7.87% | 0.77 | |
| CCMConcord Medical Services Holdings Limited | 13.15M | 4.67 | -0.00 | -28.55% | -44.6% | -9.47% | 2.43 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 616.49M | 455.04M | 330.98M | 190.9M | 198.36M | 223.01M | 485.63M | 472.08M | 537.4M | 383.96M |
| Revenue Growth % | 0.02% | -0.26% | -0.27% | -0.42% | 0.04% | 0.12% | 1.18% | -0.03% | 0.14% | -0.29% |
| Cost of Goods Sold | 353.34M | 286.54M | 232.98M | 171.14M | 214.19M | 209.93M | 542.53M | 624.49M | 614.01M | 463.12M |
| COGS % of Revenue | 0.57% | 0.63% | 0.7% | 0.9% | 1.08% | 0.94% | 1.12% | 1.32% | 1.14% | 1.21% |
| Gross Profit | 263.15M | 168.5M | 98M | 19.76M | -15.83M | 13.08M | -56.9M | -152.41M | -76.61M | -79.16M |
| Gross Margin % | 0.43% | 0.37% | 0.3% | 0.1% | -0.08% | 0.06% | -0.12% | -0.32% | -0.14% | -0.21% |
| Gross Profit Growth % | -0.21% | -0.36% | -0.42% | -0.8% | -1.8% | 1.83% | -5.35% | -1.68% | 0.5% | -0.03% |
| Operating Expenses | 268.89M | 337.13M | 309.85M | 319M | 421.46M | 329.08M | 401.42M | 372.64M | 386.38M | 453M |
| OpEx % of Revenue | 0.44% | 0.74% | 0.94% | 1.67% | 2.12% | 1.48% | 0.83% | 0.79% | 0.72% | 1.18% |
| Selling, General & Admin | 245.77M | 276M | 281.25M | 313.57M | 345.38M | 320.58M | 401.42M | 372.64M | 386.38M | 453M |
| SG&A % of Revenue | 0.4% | 0.61% | 0.85% | 1.64% | 1.74% | 1.44% | 0.83% | 0.79% | 0.72% | 1.18% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 23.13M | 61.12M | 28.6M | 5.43M | 76.09M | 8.5M | 0 | 0 | 0 | 0 |
| Operating Income | -5.74M | -168.63M | -211.86M | -299.24M | -437.29M | -316M | -458.32M | -525.05M | -462.99M | -532.16M |
| Operating Margin % | -0.01% | -0.37% | -0.64% | -1.57% | -2.2% | -1.42% | -0.94% | -1.11% | -0.86% | -1.39% |
| Operating Income Growth % | -1.03% | -28.36% | -0.26% | -0.41% | -0.46% | 0.28% | -0.45% | -0.15% | 0.12% | -0.15% |
| EBITDA | 151.51M | -40.81M | -122.4M | -254.23M | -380.94M | -245.22M | -363.86M | -401.86M | -344.16M | -401.4M |
| EBITDA Margin % | 0.25% | -0.09% | -0.37% | -1.33% | -1.92% | -1.1% | -0.75% | -0.85% | -0.64% | -1.05% |
| EBITDA Growth % | -0.6% | -1.27% | -2% | -1.08% | -0.5% | 0.36% | -0.48% | -0.1% | 0.14% | -0.17% |
| D&A (Non-Cash Add-back) | 157.25M | 127.81M | 89.45M | 45.02M | 56.35M | 70.79M | 94.46M | 123.19M | 118.83M | 130.76M |
| EBIT | 17.38M | -107.5M | -183.26M | -293.81M | -361.2M | -307.5M | -458.32M | -525.05M | -462.99M | -476.38M |
| Net Interest Income | -30.77M | -61.34M | -77.88M | -32.06M | -19.54M | -72.92M | -67.89M | -110.34M | -154.84M | -179.22M |
| Interest Income | 22.45M | 27.98M | 12.08M | 14.17M | 9.16M | 8.44M | 5.89M | 10.02M | 10.83M | 13.98M |
| Interest Expense | 53.21M | 89.33M | 89.96M | 46.23M | 28.7M | 81.36M | 73.79M | 120.36M | 165.67M | 193.2M |
| Other Income/Expense | 489K | -35.97M | -42.04M | 74M | 46.22M | -125.65M | -70.92M | -314.85M | -92.61M | -137.42M |
| Pretax Income | -5.25M | -204.6M | -253.9M | -225.25M | -391.08M | -441.65M | -529.24M | -839.9M | -555.59M | -669.58M |
| Pretax Margin % | -0.01% | -0.45% | -0.77% | -1.18% | -1.97% | -1.98% | -1.09% | -1.78% | -1.03% | -1.74% |
| Income Tax | 74.03M | 60.49M | 31.79M | 34.05M | -38.99M | -37.62M | -6.57M | -70.91M | -24.57M | -17.5M |
| Effective Tax Rate % | 14.9% | 1.28% | 1.12% | 1.04% | 0.79% | 0.7% | 0.51% | 0.58% | 0.54% | 0.46% |
| Net Income | -78.3M | -261.87M | -284.32M | -234.88M | -307.05M | -309.99M | -271.43M | -489.66M | -297.66M | -308.24M |
| Net Margin % | -0.13% | -0.58% | -0.86% | -1.23% | -1.55% | -1.39% | -0.56% | -1.04% | -0.55% | -0.8% |
| Net Income Growth % | -1.63% | -2.34% | -0.09% | 0.17% | -0.31% | -0.01% | 0.12% | -0.8% | 0.39% | -0.04% |
| Net Income (Continuing) | -79.28M | -265.08M | -285.68M | -259.3M | -352.09M | -404.03M | -522.67M | -768.99M | -531.02M | -652.08M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 43.4M | 65.59M | 80.87M | 1.84B | 2.01B | 3.06B | 4.11B | 3.88B | 3.87B | 3.9B |
| EPS (Diluted) | -523.80 | -1804.20 | -1967.10 | -2484.90 | -3818.10 | -4600.50 | -5635.50 | -3362.70 | -2044.20 | -2116.80 |
| EPS Growth % | -1.8% | -2.44% | -0.09% | -0.26% | -0.54% | -0.2% | -0.22% | 0.4% | 0.39% | -0.04% |
| EPS (Basic) | -523.80 | -1804.20 | -1967.10 | -2484.90 | -3818.10 | -6987.00 | -5635.50 | -3362.70 | -2044.20 | -2116.80 |
| Diluted Shares Outstanding | 149.5K | 145.13K | 144.53K | 144.57K | 144.7K | 145.6K | 145.6K | 145.6K | 145.6K | 145.6K |
| Basic Shares Outstanding | 149.5K | 145.13K | 144.53K | 94.53K | 80.43K | 44.37K | 48.17K | 145.6K | 145.6K | 145.6K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.3B | 1.19B | 1.11B | 1.23B | 282.49M | 676M | 584.48M | 759.8M | 617.21M | 983.97M |
| Cash & Short-Term Investments | 545.44M | 189.91M | 98.19M | 454.74M | 74.31M | 334.26M | 157.39M | 158.28M | 58.14M | 350.85M |
| Cash Only | 485.44M | 189.91M | 98.19M | 404.74M | 74.31M | 334.26M | 157.39M | 158.28M | 58.14M | 216.22M |
| Short-Term Investments | 60M | 0 | 0 | 50M | 0 | 0 | 0 | 0 | 0 | 134.62M |
| Accounts Receivable | 383.54M | 301.05M | 296.32M | 203.09M | 121.15M | 188.16M | 383.04M | 130.27M | 73.5M | 51.17M |
| Days Sales Outstanding | 227.08 | 241.48 | 326.78 | 388.32 | 222.92 | 307.96 | 287.89 | 100.72 | 49.92 | 48.64 |
| Inventory | 3.9M | 5.92M | 6.28M | 3.36M | 4.34M | 21.61M | 38.09M | 84.83M | 40.35M | 33.44M |
| Days Inventory Outstanding | 4.03 | 7.54 | 9.84 | 7.16 | 7.4 | 37.57 | 25.62 | 49.58 | 23.98 | 26.36 |
| Other Current Assets | 632.54M | 697.24M | 855.81M | 654.09M | 78.42M | 128.31M | 3.25M | 386.41M | 445.23M | 548.52M |
| Total Non-Current Assets | 2.3B | 2.03B | 2.35B | 3.36B | 4.01B | 4.66B | 5.65B | 5.25B | 5.44B | 5.74B |
| Property, Plant & Equipment | 918.82M | 775.34M | 793.57M | 1.22B | 2.55B | 3.2B | 3.35B | 3.45B | 4.13B | 4.01B |
| Fixed Asset Turnover | 0.67x | 0.59x | 0.42x | 0.16x | 0.08x | 0.07x | 0.15x | 0.14x | 0.13x | 0.10x |
| Goodwill | 0 | 0 | 0 | 165.17M | 210.44M | 213.66M | 581.88M | 575.43M | 575.43M | 572.22M |
| Intangible Assets | 473.23M | 459M | 455.73M | 895.17M | 532.49M | 522.82M | 1.07B | 762.09M | 323.29M | 680.37M |
| Long-Term Investments | 253.14M | 232.25M | 754.33M | 388.36M | 64.95M | 313.02M | 390.63M | 437.87M | 394.71M | 472.17M |
| Other Non-Current Assets | 625.8M | 65.37M | 8.58M | 4.89M | 661.14M | 107.47M | 13.58M | 23.19M | 11.43M | 5.87M |
| Total Assets | 3.6B | 3.23B | 3.47B | 4.59B | 4.3B | 5.33B | 6.23B | 6B | 6.05B | 6.73B |
| Asset Turnover | 0.17x | 0.14x | 0.10x | 0.04x | 0.05x | 0.04x | 0.08x | 0.08x | 0.09x | 0.06x |
| Asset Growth % | 0.22% | -0.1% | 0.07% | 0.32% | -0.06% | 0.24% | 0.17% | -0.04% | 0.01% | 0.11% |
| Total Current Liabilities | 1.31B | 951.06M | 1.11B | 870.26M | 627.45M | 512.12M | 804.52M | 1.12B | 1.95B | 2.13B |
| Accounts Payable | 808K | 2.04M | 4.56M | 5.44M | 8.28M | 18.63M | 102.51M | 146.75M | 129.24M | 199.39M |
| Days Payables Outstanding | 0.83 | 2.6 | 7.15 | 11.6 | 14.1 | 32.4 | 68.96 | 85.77 | 76.82 | 157.15 |
| Short-Term Debt | 716.15M | 724.62M | 794.47M | 249.2M | 0 | 148.88M | 299.35M | 512.58M | 1.04B | 1.03B |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 149.53M | 71.54M | 173.88M | 571M | 521.7M | 0 | 180M | 250.18M | 287.03M | 0 |
| Current Ratio | 0.99x | 1.26x | 1.00x | 1.41x | 0.45x | 1.32x | 0.73x | 0.68x | 0.32x | 0.46x |
| Quick Ratio | 0.99x | 1.25x | 1.00x | 1.41x | 0.44x | 1.28x | 0.68x | 0.60x | 0.30x | 0.45x |
| Cash Conversion Cycle | 230.27 | 246.43 | 329.48 | 383.88 | 216.21 | 313.14 | 244.55 | 64.53 | -2.92 | -82.15 |
| Total Non-Current Liabilities | 855.65M | 1.05B | 1.34B | 1.44B | 1.78B | 2.42B | 2.68B | 2.87B | 2.36B | 2.98B |
| Long-Term Debt | 804.1M | 464.27M | 799.05M | 720.04M | 1.29B | 1.97B | 2.2B | 2.49B | 2.01B | 2.71B |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 218.82M | 223.48M | 214.22M | 199.95M | 193.01M | 138.89M |
| Deferred Tax Liabilities | 48.51M | 49.66M | 73.58M | 165.65M | 165.44M | 153.34M | 184.42M | 112.58M | 99.54M | 82.87M |
| Other Non-Current Liabilities | 49.31M | 52.6M | 469.67M | 555.56M | 104.74M | 76.73M | 84.46M | 64.08M | 4.53M | 47.83M |
| Total Liabilities | 2.17B | 2B | 2.45B | 2.31B | 2.41B | 2.93B | 3.49B | 3.99B | 4.31B | 5.11B |
| Total Debt | 1.52B | 1.19B | 1.24B | 938.11M | 1.52B | 2.35B | 2.73B | 3.24B | 3.3B | 3.93B |
| Net Debt | 1.03B | 998.99M | 1.14B | 533.37M | 1.45B | 2.02B | 2.58B | 3.08B | 3.24B | 3.71B |
| Debt / Equity | 1.06x | 0.97x | 1.22x | 0.41x | 0.81x | 0.98x | 1.00x | 1.61x | 1.89x | 2.43x |
| Debt / EBITDA | 10.03x | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 6.83x | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -0.11x | -1.89x | -2.36x | -6.47x | -15.24x | -3.88x | -6.21x | -4.36x | -2.79x | -2.75x |
| Total Equity | 1.43B | 1.23B | 1.01B | 2.27B | 1.89B | 2.4B | 2.74B | 2.02B | 1.75B | 1.62B |
| Equity Growth % | -0.2% | -0.14% | -0.18% | 1.24% | -0.17% | 0.27% | 0.14% | -0.27% | -0.13% | -0.07% |
| Book Value per Share | 9590.56 | 8487.18 | 7022.05 | 15729.02 | 13056.24 | 16489.22 | 18844.24 | 13843.80 | 11998.54 | 11110.91 |
| Total Shareholders' Equity | 1.39B | 1.17B | 934.05M | 437.42M | -122.76M | -662.96M | -1.37B | -1.86B | -2.12B | -2.28B |
| Common Stock | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K | 105K |
| Retained Earnings | -625.62M | -598.2M | -879.39M | -1.23B | -1.79B | -2.46B | -3.28B | -3.77B | -4.06B | -4.37B |
| Treasury Stock | -6K | -8K | -8K | -8K | -8K | -8K | -7K | -7K | -7K | -7K |
| Accumulated OCI | -46.57M | -87.97M | -47.42M | -88.62M | -97.28M | -46.43M | -29.5M | -27.77M | -65.42M | -77.35M |
| Minority Interest | 43.4M | 65.59M | 80.87M | 1.84B | 2.01B | 3.06B | 4.11B | 3.88B | 3.87B | 3.9B |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -175.14M | -78.08M | 26.73M | -38.59M | -195.35M | -229.77M | -359.31M | -216.69M | -276.47M | -397.75M |
| Operating CF Margin % | -0.28% | -0.17% | 0.08% | -0.2% | -0.98% | -1.03% | -0.74% | -0.46% | -0.51% | -1.04% |
| Operating CF Growth % | -1.36% | 0.55% | 1.34% | -2.44% | -4.06% | -0.18% | -0.56% | 0.4% | -0.28% | -0.44% |
| Net Income | -78.3M | -261.87M | -284.32M | -234.88M | -307.05M | -309.99M | -271.43M | -489.66M | -297.66M | -652.08M |
| Depreciation & Amortization | 158.34M | 129.01M | 94.71M | 54.63M | 65.81M | 80.3M | 104.08M | 132.81M | 128.45M | 130.76M |
| Stock-Based Compensation | 8.08M | 8.4M | 11.64M | 11.14M | 20.59M | 20.62M | 14.68M | -5.92M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.65M |
| Other Non-Cash Items | 47.81M | 86.66M | 159.14M | -2.75M | 84.24M | 79.67M | -90.91M | 206.23M | -92.78M | 288.55M |
| Working Capital Changes | -311.07M | -40.28M | 45.56M | 133.27M | -58.94M | -100.37M | -115.74M | -60.16M | -14.49M | -149.33M |
| Change in Receivables | 43.28M | 9.92M | 43.41M | 48.38M | 3.57M | -6.17M | -64.45M | 644K | 36.45M | 12.02M |
| Change in Inventory | 315K | -1.92M | -554K | 1.8M | -1.83M | -14.45M | -4.35M | -46.75M | 44.49M | 6.5M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93.05M |
| Cash from Investing | -391.08M | -74.85M | -313.01M | -1B | -1.07B | -533.88M | -565.98M | -118.79M | -47.68M | -593.44M |
| Capital Expenditures | -181.97M | -117.99M | -289.1M | -764.4M | -700.92M | -504.7M | -760.58M | -383.77M | -115.7M | -400.67M |
| CapEx % of Revenue | 0.3% | 0.26% | 0.87% | 4% | 3.53% | 2.26% | 1.57% | 0.81% | 0.22% | 1.04% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 112.03M | 16.94M | -23.91M | 292.78M | 155.1M | -20.84M | 193.03M | 264.98M | 68.02M | -160K |
| Cash from Financing | 590.4M | -117.92M | 189.9M | 1.2B | 513.27M | 1.14B | 642.45M | 383.09M | 257.65M | 1.15B |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | -285.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 218.29M | -60.04M | -273.14M | 1.3B | -167.31M | 496.46M | 498.32M | 19.87M | 194.84M | -335.36M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -357.11M | -196.07M | -262.37M | -802.99M | -896.27M | -734.47M | -1.12B | -600.47M | -392.17M | -808.58M |
| FCF Margin % | -0.58% | -0.43% | -0.79% | -4.21% | -4.52% | -3.29% | -2.31% | -1.27% | -0.73% | -2.11% |
| FCF Growth % | -1.94% | 0.45% | -0.34% | -2.06% | -0.12% | 0.18% | -0.52% | 0.46% | 0.35% | -1.06% |
| FCF per Share | -2388.70 | -1350.94 | -1815.30 | -5554.47 | -6194.00 | -5044.44 | -7691.58 | -4124.09 | -2693.50 | -5553.45 |
| FCF Conversion (FCF/Net Income) | 2.24x | 0.30x | -0.09x | 0.16x | 0.64x | 0.74x | 1.32x | 0.44x | 0.93x | 1.29x |
| Interest Paid | 54.04M | 81.49M | 89.96M | 59.49M | 64.25M | 73.85M | 134.18M | 145.26M | 152.36M | 188.3M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 3.26M | 0 | 3.01M | 898K | 148K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -4.84% | -19.65% | -25.31% | -14.28% | -14.75% | -14.45% | -10.55% | -20.58% | -15.82% | -18.32% |
| Return on Invested Capital (ROIC) | -0.18% | -5.38% | -7.24% | -9.04% | -10.67% | -6.11% | -7.06% | -7.56% | -6.89% | -7.74% |
| Gross Margin | 42.69% | 37.03% | 29.61% | 10.35% | -7.98% | 5.87% | -11.72% | -32.28% | -14.26% | -20.62% |
| Net Margin | -12.7% | -57.55% | -85.9% | -123.04% | -154.79% | -139% | -55.89% | -103.72% | -55.39% | -80.28% |
| Debt / Equity | 1.06x | 0.97x | 1.22x | 0.41x | 0.81x | 0.98x | 1.00x | 1.61x | 1.89x | 2.43x |
| Interest Coverage | -0.11x | -1.89x | -2.36x | -6.47x | -15.24x | -3.88x | -6.21x | -4.36x | -2.79x | -2.75x |
| FCF Conversion | 2.24x | 0.30x | -0.09x | 0.16x | 0.64x | 0.74x | 1.32x | 0.44x | 0.93x | 1.29x |
| Revenue Growth | 1.58% | -26.19% | -27.26% | -42.32% | 3.91% | 12.43% | 117.76% | -2.79% | 13.84% | -28.55% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Services and other revenues | - | - | - | - | - | - | - | 518.5M | 500.07M | 372.06M |
| Services and other revenues Growth | - | - | - | - | - | - | - | - | -3.55% | -25.60% |
| Medicine income | - | - | - | - | - | - | - | 87.09M | 100.46M | 83.02M |
| Medicine income Growth | - | - | - | - | - | - | - | - | 15.36% | -17.36% |
| Equipment Leasing Revenues | - | - | - | - | - | - | - | 21.97M | 16.74M | 9.36M |
| Equipment Leasing Revenues Growth | - | - | - | - | - | - | - | - | -23.80% | -44.10% |
| Consumable and equipment sales | - | - | - | - | - | - | 217.38M | - | - | - |
| Consumable and equipment sales Growth | - | - | - | - | - | - | - | - | - | - |
| Medical service | - | - | - | - | - | - | 101.85M | - | - | - |
| Medical service Growth | - | - | - | - | - | - | - | - | - | - |
| Management services and technical services | - | - | - | - | - | - | 64.6M | - | - | - |
| Management services and technical services Growth | - | - | - | - | - | - | - | - | - | - |
| Health Care | - | - | - | - | 54.05M | 77M | - | - | - | - |
| Health Care Growth | - | - | - | - | - | 42.46% | - | - | - | - |
| Management And Technical Services | - | - | - | - | 48.42M | 36.95M | - | - | - | - |
| Management And Technical Services Growth | - | - | - | - | - | -23.69% | - | - | - | - |
| Consumable And Equipment Sales | - | - | - | - | - | 26.11M | - | - | - | - |
| Consumable And Equipment Sales Growth | - | - | - | - | - | - | - | - | - | - |
| Medicine Income | - | - | - | - | 22.78M | - | - | - | - | - |
| Medicine Income Growth | - | - | - | - | - | - | - | - | - | - |
| Food And Beverage | - | - | - | - | 9.48M | - | - | - | - | - |
| Food And Beverage Growth | - | - | - | - | - | - | - | - | - | - |
| Royalty | - | - | - | - | 5.08M | - | - | - | - | - |
| Royalty Growth | - | - | - | - | - | - | - | - | - | - |
| Network | 597.75M | 691.11M | 465.73M | 217.34M | - | - | - | - | - | - |
| Network Growth | - | 15.62% | -32.61% | -53.33% | - | - | - | - | - | - |
| Hospital | 18.74M | 50.47M | 98.23M | 144.7M | - | - | - | - | - | - |
| Hospital Growth | - | 169.35% | 94.61% | 47.31% | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| CHINA | 597.75M | 443.6M | 302.3M | 149.55M | - | - | 485.63M | 472.08M | - | - |
| CHINA Growth | - | -25.79% | -31.85% | -50.53% | - | - | - | -2.79% | - | - |
| C | - | - | - | - | 164.17M | 199.37M | - | - | - | - |
| C Growth | - | - | - | - | - | 21.44% | - | - | - | - |
| S | - | - | - | - | 34.2M | 23.64M | - | - | - | - |
| S Growth | - | - | - | - | - | -30.87% | - | - | - | - |
| SINGAPORE | 18.74M | 11.44M | 28.67M | 41.35M | - | - | - | - | - | - |
| SINGAPORE Growth | - | -38.95% | 150.62% | 44.21% | - | - | - | - | - | - |
Concord Medical Services Holdings Limited (CCM) reported $365.8M in revenue for fiscal year 2024. This represents a 19% decrease from $450.1M in 2011.
Concord Medical Services Holdings Limited (CCM) saw revenue decline by 28.6% over the past year.
Concord Medical Services Holdings Limited (CCM) reported a net loss of $163.1M for fiscal year 2024.
Concord Medical Services Holdings Limited (CCM) has a return on equity (ROE) of -18.3%. Negative ROE indicates the company is unprofitable.
Concord Medical Services Holdings Limited (CCM) had negative free cash flow of $808.6M in fiscal year 2024, likely due to heavy capital investments.